Fipronil Formulation with Benzyl Alcohol for Flea Control

Solution Overview

Problem

Current antiparasitic products, such as those containing fipronil, face challenges with crystallization and do not provide long-lasting protection against flea infestations, requiring frequent treatments and having limited persistence, which is unsatisfactory for both cats and dogs.

Innovation Solution

A liquid pharmaceutical composition containing fipronil, benzyl alcohol, and an organic solvent like monoethyl diethylene glycol, formulated to prevent crystallization and provide prolonged efficacy, is developed, allowing for easy administration and use on various animal species without wetting the entire animal.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If fipronil is formulated in conventional excipients, then the composition is easy to prepare, but crystallization occurs and persistence is limited

Engineering Contradiction:
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent changes the chemical parameters of the formulation by introducing benzyl alcohol and specific organic solvents (propylene glycol monomethyl ether, dipropylene glycol n-butyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, diethylene glycol monoethyl ether, or propylene glycol) as the vehicle system. This parameter change prevents crystallization of fipronil while maintaining ease of preparation and achieving prolonged persistence up to 13 weeks in dogs and 7 weeks in cats.

Inventive Principle:
Principle #35Parameter changes

2Speed

If conventional antiparasitic products are used, then immediate effectiveness is achieved, but frequent treatments are required due to limited persistence

Engineering Contradiction:
Core Design Contradiction:
SpeedVSDuration of action of moving object

Solution Approach 1:

The patent ensures continuity of useful action by formulating fipronil in a vehicle system that maintains the active ingredient in solution, preventing crystallization and degradation. This allows the composition to remain effective throughout the extended duration of protection (13 weeks in dogs, 7 weeks in cats), eliminating the need for frequent reapplication while maintaining continuous protective action.

Inventive Principle:
Principle #20Continuity of useful action

3Duration of action of moving object

If the composition provides long-lasting protection, then frequent treatments are reduced, but formulation complexity increases

Engineering Contradiction:
Core Design Contradiction:
Duration of action of moving objectVSDevice complexity

Solution Approach 1:

The patent uses a composite vehicle system combining benzyl alcohol with specific organic solvents (propylene glycol monomethyl ether, dipropylene glycol n-butyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, diethylene glycol monoethyl ether, or propylene glycol). This composite formulation achieves prolonged persistence while maintaining relative simplicity in preparation, as the components are simply mixed to form a stable solution containing fipronil.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition offers effective and prolonged protection against flea infestations, maintaining efficacy for up to 13 weeks in dogs and 7 weeks in cats, with rapid action and improved persistence compared to existing products.

Implementation Method 1

a liquid pharmaceutical composition containing, as active principle, fipronil, and as vehicle, benzyl alcohol and a suitably selected organic solvent

Methodology Applied
Scientific EffectSolvation: Solvation

Data Source

PatentEP2567618B1Pharmaceutical composition containing an N-phenylpyrazole derivative, use for the preparation of a topical veterinary drug for flea control
Publication Date: 2017.05.03
  • EP2567618B1 patent drawing

AI summary

The present Invention relates to a liquid pharmaceutical composition containing, as an active ingredient, an N-phenylpyrazole derivative, benzyl alcohol and a suitably selected organic solvent, and to the use of such a composition for the preparation of a topical veterinary antiparasitic medicinal product for the prevention and/or treatment of flea infestations in domestic animals, in particular in dogs and cats.